Preview

Cancer Urology

Advanced search

Surgical treatment of Renal Cell Carcinoma (RCC) with level III–IV tumor venous thrombosis

https://doi.org/10.17650/1726-9776-2016-12-4-21-34

Abstract

Objective: to assess the results of nephrectomy, thrombectomy in RCC patients with level III–IV tumor venous thrombosis with and without cardiopulmonary bypass.

Materials and methods. Medical data of 167 consecutive RCC patients with level III–IV tumor venous thrombosis underwent nephrectomy thrombectomy in N.N. Blokhin Russian Cancer Research Center between 1998 and 2012 were collected. Right side tumor was in 122 (73.1 %), left side – in 42 (25.1 %), bilateral – in 3 (1.8 %) cases. The extent of thrombus was defined as intrahepatic in 82 (49.1 %), supradiaphragmatic – in 85 (50.9 %) (intrapericardial – in 44 (26.3 %), intraatrial – in 39 (23.4 %), intraventricular – in 2 (1.2 %)) cases. Nephrectomy, thrombectomy with cardiopulmonary bypass was used in 9 (5.4 %), 158 (94.6 %) patients underwent radical nephrectomy with thrombectomy without CPBP and sternotomy. Intrapericardial IVC and right atrium were exposed through transdiaphragmatic approach and providing vascular control over infradiaphragmatic IVC and renal veins.

Results. Median blood loss was 6000 (600–27 000) ml. Complications rate was 62.8 %, 90-day mortality – 13.2 %. Intraoperative complications were registered in 80 (47.9 %), postoperative – in 66 (40.5 %) (grade II – 16 (9.8 %), grade IIIb – 1 (0.6 %), grade IVа – 28 (17.2 %), grade IVb – 3 (1.8 %), grade V – 18 (11.1 %)) patients. Modified thrombectomy technique insignificantly decreased blood loss compared to thrombectomy with CPB, did nоt increase complications rate including pulmonary vein thromboembolism, or mortality. Five-year overall, cancer-specific and recurrence-free survival was 46.2, 58.3 and 47.1 %, respectively. Thrombectomy technique did nоt affect survival.

Conclusion. In selected patients with mobile thrombi transdiaphragmatic approach allows to avoid the use of CPBP and decrease surgical morbidity without survival compromising.

About the Authors

M. I. Davydov
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


V. B. Matveev
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


M. I. Volkova
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


P. I. Feoktistov
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


K. P. Kuznetsov
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


I. V. Nekhaev
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


S. V. Lomidze
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


O. V. Zhuzhginova
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


K. M. Figurin
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


V. A. Chernyaev
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


E. V. Ogorodnikova
N.N. Blokhin Russian Cancer Reseach Center, Ministry of Health of Russia
Russian Federation
24 Kashirskoe Shosse, Moscow 115478


References

1. Давыдов М.И., Матвеев В.Б., Матвеев Б.П. Хирургическое лечение рака почки, осложненного венозной инвазией (пособие для врачей). М., 2003. 24 с. [Davydov M.I., Matveev V.B., Matveev B.P. Surgical treatment of kidney cancer complicated by venous invasion (guidelines for doctors). Moscow, 2003. 24 p. (In Russ.)].

2. Navia J.L., Brozzi N.A., Nowicki E.R. et al. Simplified perfusion strategy for removing retroperitoneal tumors with extensive сavoatrial involvement. J Thorac Cardiovasc Surg 2012;143(5):1014–21. DOI: 10.1016/j.jtcvs.2011.05.009. PMID: 21783206.

3. Stewart J.R., Carey J.A., McDougal W.C. et al. Cavoatrial tumor thrombectomy using cardiopulmonary bypass without circulatory arrest. Ann Thorac Surg 1991;51(5):717–22. PMID: 1850976.

4. Langenburg S.E., Blackbourne L.H., Sperling J.W. et al. Management of renal tumors involving the inferior vena cava. J Vasc Surg 1994;20(3):385–8. PMID: 8084030.

5. Shuch B., Crispen P.L., Leibovich B.C. et al. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int 2011;107(5):724–8. DOI: 10.1111/j.1464-410X.2010.09488.x. PMID: 20626391.

6. Patil M.B., Montez J., Loh-Doyle J. Level III–IV inferior vena caval thrombectomy without cardiopulmonary bypass: longterm experience with intrapericardial control. J Urol 2014;192(3):682–8. DOI: 10.1016/j.juro.2014.03.112. PMID: 24704114.

7. Kaag M.G., Toyen C., Russo P. et al. Radical nephrectomy with vena caval thrombectomy: a contemporary experience. BJU Int 2011;107(9):1386–93. DOI: 10.1111/j.1464-410X.2010.09661.x. PMID: 20883481.

8. Ciancio G., Shirodkar S.P., Soloway M.S., Salerno T.A. Techniques for avoidance of sternotomy and cardiopulmonary bypass during resection of extensive renal cell carcinoma with vena caval tumor thrombus extension above the diaphragm. J Card Surg 2009;24(6):657–60. DOI: 10.1111/j.1540-8191.2009.00880.x. PMID: 19732225.

9. Nguyen H.G., Tilki D., Dall’Era M.A. Cardiopulmonary bypass has no significant impact on survival in patients undergoing nephrectomy and level III–IV inferior vena cava thrombectomy: multi-institutional analysis. J Urol 2015;194(2):304–8. DOI: 10.1016/j.juro.2015.02.2948. PMID: 25797392.

10. Blute M.L., Boorjian S.A., Leibovich B.C. Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol 2007;178(2):440–5. DOI: 10.1016/j.juro.2007.03.121. PMID: 17561151.

11. Wagner B., Patard J.-J., Méjean A. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol 2009;55(2):452–60. DOI: 10.1016/j.eururo.2008.07.053. PMID: 18692951.


Review

For citations:


Davydov M.I., Matveev V.B., Volkova M.I., Feoktistov P.I., Kuznetsov K.P., Nekhaev I.V., Lomidze S.V., Zhuzhginova O.V., Figurin K.M., Chernyaev V.A., Ogorodnikova E.V. Surgical treatment of Renal Cell Carcinoma (RCC) with level III–IV tumor venous thrombosis. Cancer Urology. 2016;12(4):21-34. (In Russ.) https://doi.org/10.17650/1726-9776-2016-12-4-21-34

Views: 1216


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)
X